Definitive Healthcare Corp. (NASDAQ:DH) Shares Bought by New York State Common Retirement Fund

New York State Common Retirement Fund boosted its holdings in Definitive Healthcare Corp. (NASDAQ:DH) by 17.7% during the 4th quarter, Holdings Channel reports. The fund owned 336,859 shares of the company’s stock after acquiring an additional 50,762 shares during the quarter. New York State Common Retirement Fund’s holdings in Definitive Healthcare were worth $3,348,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. SG Americas Securities LLC purchased a new stake in shares of Definitive Healthcare during the third quarter worth $116,000. J.P. Morgan Private Wealth Advisors LLC bought a new stake in Definitive Healthcare in the third quarter worth $131,000. Arizona State Retirement System increased its holdings in shares of Definitive Healthcare by 13.6% during the 4th quarter. Arizona State Retirement System now owns 14,253 shares of the company’s stock valued at $142,000 after acquiring an additional 1,701 shares during the last quarter. Corton Capital Inc. raised its stake in shares of Definitive Healthcare by 17.0% in the 3rd quarter. Corton Capital Inc. now owns 19,964 shares of the company’s stock valued at $160,000 after acquiring an additional 2,898 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in Definitive Healthcare by 209.8% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 16,209 shares of the company’s stock worth $161,000 after purchasing an additional 10,977 shares during the last quarter. 98.67% of the stock is currently owned by institutional investors.

Definitive Healthcare Stock Up 0.6 %

Shares of NASDAQ:DH opened at $7.03 on Monday. Definitive Healthcare Corp. has a 12 month low of $5.53 and a 12 month high of $12.45. The company has a market cap of $828.06 million, a price-to-earnings ratio of -3.95, a PEG ratio of 6.12 and a beta of 1.41. The company has a current ratio of 2.31, a quick ratio of 2.31 and a debt-to-equity ratio of 0.20. The company has a 50-day moving average price of $7.85 and a 200 day moving average price of $8.31.

Definitive Healthcare (NASDAQ:DH) last announced its quarterly earnings results on Wednesday, February 28th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.02). The firm had revenue of $65.93 million during the quarter, compared to analysts’ expectations of $66.01 million. Definitive Healthcare had a negative net margin of 80.40% and a positive return on equity of 0.43%. As a group, equities research analysts predict that Definitive Healthcare Corp. will post 0.11 earnings per share for the current year.

Analysts Set New Price Targets

Several analysts recently weighed in on DH shares. Canaccord Genuity Group increased their target price on Definitive Healthcare from $9.00 to $10.00 and gave the company a “hold” rating in a research note on Thursday, February 29th. Barclays lifted their price target on shares of Definitive Healthcare from $10.00 to $11.00 and gave the stock an “equal weight” rating in a research report on Friday, March 1st. Needham & Company LLC downgraded shares of Definitive Healthcare from a “buy” rating to a “hold” rating in a research report on Wednesday, January 17th. Finally, Stifel Nicolaus cut their price target on shares of Definitive Healthcare from $12.00 to $11.00 and set a “buy” rating for the company in a research note on Wednesday, January 17th. Seven research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Definitive Healthcare presently has a consensus rating of “Hold” and an average target price of $11.31.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.